Salivary Gland Neoplasms Treatment Market : Analysis and Opportunity Assessment up to 2027

Salivary Gland Neoplasms Treatment: Introduction

  • Salivary glands comprise three major secretory glands: parotid, submandibular, and sublingual, and several minor glands. The function of these glands is the production and secretion of saliva. Saliva is a lubricating fluid that apart from keeping the mouth and throat moist also contains digestive enzymes that help in digesting food. It also contains antibodies and other substances that help prevent infections of the mouth and throat.
  • Salivary gland tumors are comparatively rare in comparison to the total incidence of head and neck region tumors. The overall incidence of salivary gland tumors varies across the world, from approximately 0.4 to 13.5 cases per 100,000 people. The parotid gland is the most common site of occurrence of salivary gland tumors.

Report Overview : https://www.transparencymarketresearch.com/salivary-gland-neoplasms-treatment-market.html

Key Drivers and Restraints of Global Salivary Gland Neoplasms Treatment Market

  • Cancer is the second leading cause of death globally after cardiovascular diseases. The proportion of deaths across the world due to cancer increased from 12% in 1990 to 15% in 2013. According to the World Health Organization (WHO), cancer accounts for 8.3 million deaths every year, with 70% new cases expected to be reported during the next 20 years. More than 60% of new cancer cases in the world is registered in Africa, Asia, and Central and South America, and 70% of the deaths caused by cancer globally takes place in these regions.
  • Each type of cancer requires unique treatment. Rise in prevalence of cancer and the need of personalized medicine are expected to boost the number of diagnostic tests. This is likely to provide significant opportunities to the players in the market.
  • In order to reduce mortality and morbidity rate, governments in developed and developing countries are conducting awareness campaigns to encourage people to go for early diagnosis of cancer. This, in turn, is expected to increase awareness about cancer diagnosis and treatment.
  • A number of companies have started Patient Support Programs (PSPs) to reduce the cost of treatment. For example, Roche’s Blue Tree Program offers support to cancer patients during their treatment journey.
  • High cost of drugs is one of the major concerns among patients as well as payers. The cost of cancer drugs used for the treatment has increased in the past few years, making it difficult for patients to afford the treatment. Treatment costs are covered by insurance; however, the out-of-pocket cost for the insured can also be high. Increasing costs lead to delay in treatment or complete avoidance of taking prescribed medication. These factors act as restraints of the global market.

Radiation Therapy Segment to Lead Global Market

  • The treatment regimen for salivary gland neoplasms is often decided by the type, stage or grade of the cancer. Based on cancer type, the global salivary gland neoplasms treatment market can be divided into mucoepidermoid carcinoma, adenoid cystic carcinoma, adenocarcinomas, malignant mixed tumors, and others.
  • In terms of treatment type, the global salivary gland neoplasms treatment market can be classified into surgery, radiation therapy, and chemotherapy. Radiation therapy along with surgery is the standard treatment option for most of the types of salivary gland cancers. Chemotherapy is also used, but the efficacy of chemotherapy drugs has not yet been established.

North America to Lead Global Salivary Gland Neoplasms Treatment Market

  • The global salivary gland neoplasms treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a significant market for salivary gland neoplasms treatment due to substantial focus on health care development and presence of several key players.
  • Increase in the geriatric population and high population with unhealthy habits such as tobacco consumption makes the emerging economies in Asia Pacific, Latin America, and the Middle East the most attractive markets for salivary gland neoplasms treatments. Rise in awareness and affordability of patients in developing countries such as China, India, and Brazil are expected to provide significant opportunities in the salivary gland neoplasms treatment market in these countries.

For More Details, Request A PDF Brochure Report @  https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=74348

Key Players Operating in Global Salivary Gland Neoplasms Treatment Market

Leading players in the global salivary gland neoplasms treatment market are:

  • Varian Medical Systems, Inc.
  • Siemens AG
  • Accuray Incorporated
  • Koninklijke Philips N.V.
  • Elekta AB
  • General Electric Company

Global Salivary Gland Neoplasms Treatment Market: Research Scope

Global Salivary Gland Neoplasms Treatment Market, by Cancer Type

  • Mucoepidermoid Carcinoma
  • Adenoid Cystic Carcinoma
  • Adenocarcinomas
  • Malignant Mixed Tumors
  • Others

Global Salivary Gland Neoplasms Treatment Market, by Treatment Type

  • Surgery
  • Radiation Therapy
  • Chemotherapy
Previous post Surgical Glue Market : Key Trends and Opportunity Analysis up to 2027
Next post Brachytherapy Afterloaders Market : Aims Bigger with Technological Innovations by 2027